Young Chang, Jae Young Jang, Soung Won Jeong, Do Seon Song, Hee Yeon Kim, Young Kul Jung, Tae Hyung Kim, Hyung Joon Yim, Eileen L Yoon, Ki Tae Suk, Jeong-Ju Yoo, Sang Gyune Kim, Moon Young Kim, Sung-Eun Kim, Jung-Hee Kim, Jung Gil Park, Won Kim, Dong Joon Kim
{"title":"Liver Failure versus Organ Failure in Acute-on-Chronic Liver Failure: Sequence and Consequence.","authors":"Young Chang, Jae Young Jang, Soung Won Jeong, Do Seon Song, Hee Yeon Kim, Young Kul Jung, Tae Hyung Kim, Hyung Joon Yim, Eileen L Yoon, Ki Tae Suk, Jeong-Ju Yoo, Sang Gyune Kim, Moon Young Kim, Sung-Eun Kim, Jung-Hee Kim, Jung Gil Park, Won Kim, Dong Joon Kim","doi":"10.5009/gnl250299","DOIUrl":null,"url":null,"abstract":"<p><strong>Background/aims: </strong>Acute-on-chronic liver failure (ACLF) is characterized by the acute decompensation of the liver in patients with preexisting chronic liver disease or cirrhosis, often resulting in multiorgan failure and high short-term mortality. This study aimed to investigate the sequence of organ failures, particularly liver and renal failure, and their impact on the short-term survival in ACLF patients.</p><p><strong>Methods: </strong>We analyzed data from 1,765 patients in a prospective Korean ACLF cohort, focusing on the timing of liver and renal failures. Overall survival (OS) was assessed using Kaplan-Meier survival analysis with the log-rank test, and multivariate analysis was performed using a Cox proportional hazards model.</p><p><strong>Results: </strong>Patients with initial liver failure had significantly worse OS compared to those without liver failure (adjusted hazard ratio [aHR], 3.6; p=0.008), and those who developed liver failure during the disease course had an even poorer prognosis (aHR, 5.7; p=0.002). There was no significant difference in OS between patients without renal failure and those with initial renal failure (aHR, 0.8; p=0.508). However, renal failure that developed during hospitalization was associated with a worse prognosis (aHR, 1.9; p=0.056). Patients with initial renal failure had significantly better OS than those with initial liver failure (aHR 2.4, p=0.040).</p><p><strong>Conclusions: </strong>Organ failure developing during hospitalization is more detrimental than failure present at admission. ACLF with initial renal failure has a better prognosis than ACLF with initial liver failure. ACLF patients with initial renal failure have a 28-day survival rate exceeding 90% if renal failure is present initially; however, this rate significantly decreases if renal failure occurs during hospitalization.</p>","PeriodicalId":12885,"journal":{"name":"Gut and Liver","volume":" ","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2026-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gut and Liver","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5009/gnl250299","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background/aims: Acute-on-chronic liver failure (ACLF) is characterized by the acute decompensation of the liver in patients with preexisting chronic liver disease or cirrhosis, often resulting in multiorgan failure and high short-term mortality. This study aimed to investigate the sequence of organ failures, particularly liver and renal failure, and their impact on the short-term survival in ACLF patients.
Methods: We analyzed data from 1,765 patients in a prospective Korean ACLF cohort, focusing on the timing of liver and renal failures. Overall survival (OS) was assessed using Kaplan-Meier survival analysis with the log-rank test, and multivariate analysis was performed using a Cox proportional hazards model.
Results: Patients with initial liver failure had significantly worse OS compared to those without liver failure (adjusted hazard ratio [aHR], 3.6; p=0.008), and those who developed liver failure during the disease course had an even poorer prognosis (aHR, 5.7; p=0.002). There was no significant difference in OS between patients without renal failure and those with initial renal failure (aHR, 0.8; p=0.508). However, renal failure that developed during hospitalization was associated with a worse prognosis (aHR, 1.9; p=0.056). Patients with initial renal failure had significantly better OS than those with initial liver failure (aHR 2.4, p=0.040).
Conclusions: Organ failure developing during hospitalization is more detrimental than failure present at admission. ACLF with initial renal failure has a better prognosis than ACLF with initial liver failure. ACLF patients with initial renal failure have a 28-day survival rate exceeding 90% if renal failure is present initially; however, this rate significantly decreases if renal failure occurs during hospitalization.
期刊介绍:
Gut and Liver is an international journal of gastroenterology, focusing on the gastrointestinal tract, liver, biliary tree, pancreas, motility, and neurogastroenterology. Gut and Liver delivers up-to-date, authoritative papers on both clinical and research-based topics in gastroenterology. The Journal publishes original articles, case reports, brief communications, letters to the editor and invited review articles in the field of gastroenterology. The Journal is operated by internationally renowned editorial boards and designed to provide a global opportunity to promote academic developments in the field of gastroenterology and hepatology.
Gut and Liver is jointly owned and operated by 8 affiliated societies in the field of gastroenterology, namely: the Korean Society of Gastroenterology, the Korean Society of Gastrointestinal Endoscopy, the Korean Society of Neurogastroenterology and Motility, the Korean College of Helicobacter and Upper Gastrointestinal Research, the Korean Association for the Study of Intestinal Diseases, the Korean Association for the Study of the Liver, the Korean Pancreatobiliary Association, and the Korean Society of Gastrointestinal Cancer.